- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03390751
Atropine Weight and Risk of Postoperative Confusion in the Elderly (ATROPAGE)
29. juli 2020 opdateret af: University Hospital, Toulouse
Atropine Weight and Risk of Postoperative Confusion After Hip Fracture Surgery or Prosthetic Surgery of the Lower Limb, in the Elderly
The identification of a high atropine load of treatment received during hospitalization as a predictor of postoperative confusion could have various benefits:
- Pharmacoepidemiological: identify factors associated with postoperative confusion
- Clinics: by favoring treatments with a low atropine load during anesthesia, the management of patients hospitalized in orthopedics. Similarly, stopping or re-evaluating treatments with a high atropine weight for scheduled surgery is an easy step to take.
- Socio-economic: by reducing the costs related to the occurrence of a confusional syndrome (over-treatment, prolonged hospital stay, loss of autonomy, institutionalization of patients...).
In total, the present study would improve the daily management of hospitalized patients and the practices of clinicians, by offering a decision-making aid.
Studieoversigt
Undersøgelsestype
Observationel
Tilmelding (Forventet)
130
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Toulouse, Frankrig, 31000
- Rekruttering
- Pierre-Paul-Riquet University Hospital
-
Kontakt:
- Vincent Minville, MD
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
65 år og ældre (Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
The recruitment of patients will be ensured from the consultation of anesthesia or the entry into hospitalization by the anesthesia team of the orthopedic surgery department of the Hospital.
Beskrivelse
Inclusion Criteria:
- Admitted to the orthopedic department for surgical management of a fracture of the upper end of the femur in emergency or for the installation of a hip or knee prosthesis
- Patient able to understand and respond to the protocol
- No opposition to the collection of data of the patient or his / her designee
Exclusion Criteria:
- Pre-existing confusion to surgery, detected by the CAM scale
- Serious or moderate head trauma less than three months old
- Removing / installing prosthesis.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
---|---|
Aged patients
Data collection of patients admitted to the orthopedic department of the University Hospital of Toulouse for surgical management of a fracture of the upper end of the femur in emergency or for the installation of a hip or knee prosthesis.
|
The collection of data will be done by interrogation of the patient and his family / entourage and rereading of medical records
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Association between atropine load of medications on the risk of postoperative confusion
Tidsramme: up to 7 days
|
Occurrence of a postoperative confusion syndrome performed by Confusion Assessment Method (CAM) scale once a day.
The CAM is a validated scale as a diagnostic scale for confusional syndrome at the patient's bedside with four parts : 1) confusion and fluctuation of symptoms, 2) inattention, 3) disorganization of thought, 4) disorder of consciousness.
|
up to 7 days
|
Atropinic load of drugs
Tidsramme: up to 7 days
|
The DURAN scale is the most recent and most comprehensive atropine load evaluation scale.
This scale classifies the evaluated drugs into three categories: no anticholinergic power (atropine weight = 0), low anticholinergic activity (atropine weight = 1), high atropinic power (atropine weight = 3).
All drugs received by the patient during 7 days will be classified with the Duran scale.
|
up to 7 days
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Duration of hospitalization
Tidsramme: Up to discharge, an average of ten days
|
Number of days of hospitalization (days) between surgery and discharge.
Association between atropinic load of drugs and duration of hospitalization will be evaluated.
|
Up to discharge, an average of ten days
|
Autonomy
Tidsramme: Month 3
|
Description of autonomy of the patient at three months of surgery evaluated by the Activity Daily Living scale (ADL).
The ADL scale evaluates activities of daily living: washing, dressing, going to the bathroom, ensuring transfers, continence and food.
Each item is rated according to a level of dependence: independent (1 point), with assistance (0.5 points), unable to achieve (0 points).
A total of 6 points indicates a total autonomy, and 0 a total dependency.
|
Month 3
|
Cognitive dysfunction
Tidsramme: baseline
|
Appearance postoperative cognitive dysfunction by the Mini Mental State (MMS).
the total score of MMS wil be collected.
|
baseline
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Vincent Minville, University Hospital, Toulouse
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
14. december 2017
Primær færdiggørelse (Forventet)
1. januar 2021
Studieafslutning (Forventet)
1. januar 2022
Datoer for studieregistrering
Først indsendt
16. november 2017
Først indsendt, der opfyldte QC-kriterier
3. januar 2018
Først opslået (Faktiske)
4. januar 2018
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
30. juli 2020
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
29. juli 2020
Sidst verificeret
1. juli 2020
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- RC31/17/0202
- 2017-A01847-46 (Registry Identifier: ANSM Register)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Data collection
-
Acorai ABRekruttering
-
Memorial Sloan Kettering Cancer CenterAfsluttetProstatakræftForenede Stater
-
Marmara UniversityAfsluttetCerebral Parese | Brachial Plexus PareseKalkun
-
Midwest Heart & Vascular SpecialistsRekrutteringAL Amyloidose | Amyloid | Hjerte amyloidose | Amyloidose Hjerte | Systemisk amyloidose | ATTR Amyloidose vildtype | Infiltrativ kardiomyopati, amyloidForenede Stater
-
Massachusetts General HospitalRekruttering
-
University of FloridaTilmelding efter invitation
-
Applied Biology, Inc.Trukket tilbageAndrogenetisk alopeci | Hårtab | Hårtab/skaldethed | Kvindelig mønster skaldethedForenede Stater
-
Children's Hospital of Fudan UniversityGuangzhou Women and Children's Medical Center; Maternal and Child Health... og andre samarbejdspartnereRekrutteringNeonatal encefalopati | Mistænkt neonatal encefalopatiKina
-
Teal Health, Inc.Aktiv, ikke rekrutterendeHuman Papilloma Virus | Human Papilloma Virus Infektion Type 16 | Human Papilloma Virus Infektion Type 18Forenede Stater
-
M.D. Anderson Cancer CenterAfsluttetBrystkræftForenede Stater